Raub Brock Capital Management LP Decreases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Raub Brock Capital Management LP cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 31,592 shares of the healthcare conglomerate’s stock after selling 1,037 shares during the quarter. UnitedHealth Group accounts for about 3.7% of Raub Brock Capital Management LP’s portfolio, making the stock its 13th largest holding. Raub Brock Capital Management LP’s holdings in UnitedHealth Group were worth $16,546,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the business. Norges Bank purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $6,375,744,000. GAMMA Investing LLC increased its holdings in shares of UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $1,914,740,000. Amundi increased its holdings in shares of UnitedHealth Group by 97.2% during the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after purchasing an additional 2,991,470 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Kristen Gil bought 3,700 shares of the firm’s stock in a transaction dated Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director now owns 3,818 shares of the company’s stock, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 in the last 90 days. 0.28% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on UNH. Wolfe Research cut their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a report on Tuesday, May 20th. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Deutsche Bank Aktiengesellschaft cut their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a report on Wednesday, May 14th. Hsbc Global Res lowered shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Finally, Mizuho lowered their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $426.52.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $313.39 on Friday. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The business has a fifty day moving average of $386.66 and a two-hundred day moving average of $474.19. The company has a market cap of $284.28 billion, a P/E ratio of 20.22, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the firm earned $6.91 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.82%. UnitedHealth Group’s payout ratio is presently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.